Here is what the page “Breast Cancer in Older Women: Why Tailored Treatments Are Needed, According to STAT Wunder” contains. Breast cancer can behave differently in older women, and a growing body of evidence suggests that more tailored treatments could improve outcomes for this group. Neil Carleton, a physician and researcher recognized as a STAT Wunderkind, is working to turn that evidence into clinical reality. His work focuses on understanding how breast cancer biology and patient factors like age and overall health interact, with the goal of personalizing therapy for older patients who are often underrepresented in clinical trials.
Why it matters: Older women with breast cancer may face overtreatment or undertreatment because standard guidelines are often based on studies of younger, healthier patients. Carleton’s research aims to fill that gap by identifying which older women can safely avoid aggressive therapies and which may need more intensive care. For the complete material, the listing points back to the source inside the network.